Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer Cases

Figure 1

The flowchart of the study. Firstly, the expression of TCF19 is investigated within the different ages, stages, genders, and tissues, then the GSEA is utilized to explore the relevant immune signaling pathways based on the expression level of TCF19. Secondly, we apply the univariate Cox regression model and the Wilcoxon test between the nonresponder and responder groups of the immunotherapeutic response cohort to identify the survival association. Finally, we perform the drug sensitivity correlation with TCF19 expression in renal clear cell carcinoma.